Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Work In Process (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Work In Process for 14 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Work In Process rose 35.47% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 35.47% increase, with the full-year FY2025 number at $2.9 million, up 35.47% from a year prior.
  • Work In Process was $2.9 million for Q4 2025 at Lemaitre Vascular, up from $1.7 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $10.6 million in Q3 2021 to a low of $1.7 million in Q3 2025.
  • A 5-year average of $4.2 million and a median of $3.2 million in 2022 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: soared 88.52% in 2021, then tumbled 66.75% in 2022.
  • Lemaitre Vascular's Work In Process stood at $9.4 million in 2021, then crashed by 61.11% to $3.7 million in 2022, then dropped by 21.65% to $2.9 million in 2023, then dropped by 24.82% to $2.2 million in 2024, then skyrocketed by 35.47% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Work In Process are $2.9 million (Q4 2025), $1.7 million (Q3 2025), and $2.3 million (Q2 2025).